IL276799A - Porcine trypsin variants - Google Patents
Porcine trypsin variantsInfo
- Publication number
- IL276799A IL276799A IL276799A IL27679920A IL276799A IL 276799 A IL276799 A IL 276799A IL 276799 A IL276799 A IL 276799A IL 27679920 A IL27679920 A IL 27679920A IL 276799 A IL276799 A IL 276799A
- Authority
- IL
- Israel
- Prior art keywords
- variants
- porcine trypsin
- porcine
- trypsin
- Prior art date
Links
- 102000004142 Trypsin Human genes 0.000 title 1
- 108090000631 Trypsin Proteins 0.000 title 1
- 239000012588 trypsin Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21004—Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Enzymes And Modification Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Meat, Egg Or Seafood Products (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18158034 | 2018-02-22 | ||
| PCT/EP2019/054400 WO2019162423A1 (en) | 2018-02-22 | 2019-02-22 | Variants of porcine trypsin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL276799A true IL276799A (en) | 2020-10-29 |
Family
ID=61274085
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL276799A IL276799A (en) | 2018-02-22 | 2020-08-19 | Porcine trypsin variants |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11518988B2 (enExample) |
| EP (1) | EP3755794A1 (enExample) |
| JP (2) | JP7432516B2 (enExample) |
| KR (1) | KR102863070B1 (enExample) |
| CN (1) | CN111989401A (enExample) |
| AU (1) | AU2019225972B2 (enExample) |
| BR (1) | BR112020016954A2 (enExample) |
| CA (1) | CA3091943A1 (enExample) |
| IL (1) | IL276799A (enExample) |
| MX (1) | MX2020008766A (enExample) |
| MY (1) | MY200951A (enExample) |
| SG (1) | SG11202008026WA (enExample) |
| WO (1) | WO2019162423A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019162423A1 (en) | 2018-02-22 | 2019-08-29 | Sanofi-Aventis Deutschland Gmbh | Variants of porcine trypsin |
| CN111676211B (zh) * | 2020-05-15 | 2022-07-19 | 天津科技大学 | 一种抗自切和高比活力胰蛋白酶突变体 |
| CN119552847B (zh) * | 2025-01-21 | 2025-04-11 | 四川大学 | 链霉菌胰蛋白酶自剪切位点突变体及其应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010022452A (ko) * | 1997-07-31 | 2001-03-15 | 추후제출 | 플라비바이러스 감염에 대한 재조합 다이머형 엔벨롭 백신 |
| US7622113B2 (en) * | 2003-12-08 | 2009-11-24 | The United States Of America As Represented By The Department Of Health And Human Services | Monoclonal antibodies that bind or neutralize dengue virus |
| ATE517919T1 (de) * | 2005-09-14 | 2011-08-15 | Sanofi Aventis Deutschland | Spaltung von insulinvorstufen durch eine trypsinvariante |
| BR112013009649A2 (pt) * | 2010-10-29 | 2016-07-12 | Merck Sharp & Dohme | composição imunogênica, métodos para provocar uma resposta imune protetora em um paciente humano e para fornecer proteção imune em seres humanos contra doença, e, uso de uma composição |
| US9267114B2 (en) * | 2012-11-07 | 2016-02-23 | Southern Research Institute | Flavivirus envelope protein mutations affecting virion disassembly |
| WO2019162423A1 (en) * | 2018-02-22 | 2019-08-29 | Sanofi-Aventis Deutschland Gmbh | Variants of porcine trypsin |
-
2019
- 2019-02-22 WO PCT/EP2019/054400 patent/WO2019162423A1/en not_active Ceased
- 2019-02-22 BR BR112020016954-4A patent/BR112020016954A2/pt unknown
- 2019-02-22 SG SG11202008026WA patent/SG11202008026WA/en unknown
- 2019-02-22 AU AU2019225972A patent/AU2019225972B2/en active Active
- 2019-02-22 JP JP2020544428A patent/JP7432516B2/ja active Active
- 2019-02-22 US US16/971,491 patent/US11518988B2/en active Active
- 2019-02-22 KR KR1020207026991A patent/KR102863070B1/ko active Active
- 2019-02-22 CN CN201980026139.4A patent/CN111989401A/zh active Pending
- 2019-02-22 MX MX2020008766A patent/MX2020008766A/es unknown
- 2019-02-22 MY MYPI2020004295A patent/MY200951A/en unknown
- 2019-02-22 CA CA3091943A patent/CA3091943A1/en active Pending
- 2019-02-22 EP EP19705541.1A patent/EP3755794A1/en active Pending
-
2020
- 2020-08-19 IL IL276799A patent/IL276799A/en unknown
-
2022
- 2022-10-27 US US18/050,446 patent/US11952602B2/en active Active
-
2023
- 2023-12-27 JP JP2023220226A patent/JP7699196B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2020130880A (ru) | 2022-03-22 |
| CA3091943A1 (en) | 2019-08-29 |
| US11952602B2 (en) | 2024-04-09 |
| BR112020016954A2 (pt) | 2020-12-29 |
| JP7699196B2 (ja) | 2025-06-26 |
| MX2020008766A (es) | 2020-12-07 |
| KR20200124255A (ko) | 2020-11-02 |
| US20200377873A1 (en) | 2020-12-03 |
| RU2020130880A3 (enExample) | 2022-03-22 |
| NZ768123A (en) | 2026-02-27 |
| SG11202008026WA (en) | 2020-09-29 |
| JP2021514194A (ja) | 2021-06-10 |
| KR102863070B1 (ko) | 2025-09-22 |
| AU2019225972A1 (en) | 2020-10-15 |
| JP2024038140A (ja) | 2024-03-19 |
| US20230303994A1 (en) | 2023-09-28 |
| AU2019225972B2 (en) | 2024-10-17 |
| WO2019162423A1 (en) | 2019-08-29 |
| MY200951A (en) | 2024-01-25 |
| CN111989401A (zh) | 2020-11-24 |
| EP3755794A1 (en) | 2020-12-30 |
| US11518988B2 (en) | 2022-12-06 |
| JP7432516B2 (ja) | 2024-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279468A (en) | Crystallographic modifications of odeviccibat | |
| GB201706477D0 (en) | Modification of polypeptides | |
| IL276067A (en) | Production of glucagon peptides | |
| SG11202101269WA (en) | Crosslinking of polyaryletherketones | |
| SG11202008026WA (en) | Variants of porcine trypsin | |
| GB201810052D0 (en) | Polypeptide | |
| IL275536A (en) | Methods for quantification of polypeptides | |
| IL276107A (en) | Crystalline forms of psoorstam | |
| GB201806638D0 (en) | Maintaining state of speculation | |
| SG11202105136WA (en) | Application of chidamide | |
| HK40043243A (en) | Variants of porcine trypsin | |
| EP3969965C0 (en) | WRISTWATCH | |
| CA190045S (en) | Portion of an insole | |
| CA189475S (en) | Portion of an insole | |
| SG11202105935XA (en) | Wrist rest | |
| GB202107426D0 (en) | Virtulization of tangible object components | |
| PT3901141T (pt) | Nova forma de isoquinolinossulfonamida | |
| CA198245S (en) | Seamless bezel setting | |
| CA186671S (en) | Watch case | |
| ZAA201801308S (en) | Watch | |
| ZAA201801306S (en) | Watch | |
| ZAA201801307S (en) | Watch | |
| PH32018000460S1 (en) | Watch | |
| ZAA201801305S (en) | Watch case | |
| PH32018000727S1 (en) | Watch case |